NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation
Open Access
- 16 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (5), 873-882
- https://doi.org/10.1038/sj.bjc.6605574
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206Journal of Clinical Oncology, 2008
- Altered pattern of Cul‐1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levelsThe Journal of Pathology, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaThe New England Journal of Medicine, 2007
- NUB1 Suppresses the Formation of Lewy Body-Like Inclusions by Proteasomal Degradation of Synphilin-1The American Journal of Pathology, 2006
- Ubiquitination of p21Cip1/WAF1 by SCFSkp2: Substrate Requirement and Ubiquitination Site SelectionBiochemistry, 2005
- Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cellsThe Esophagus, 2005
- Novel approaches in the therapy of metastatic renal cell carcinomaWorld Journal of Urology, 2005
- NEDD8 Ultimate Buster-1L Interacts with the Ubiquitin-like Protein FAT10 and Accelerates Its DegradationOnline Journal of Public Health Informatics, 2004
- Targeting of NEDD8 and Its Conjugates for Proteasomal Degradation by NUB1Journal of Biological Chemistry, 2001
- Identification of NEDD8-Conjugation Site in Human Cullin-2Biochemical and Biophysical Research Communications, 1999